The reality is more nuanced: thyroid disease requires informed decision-making and close monitoring, but it doesn't universally prohibit GLP-1 therapy
Susan Cornell, PharmD, CDCES, FAPhA, FADCES In the post-era of cardiovascular outcome trials (CVOTs), the evidence continues to mount regarding the benefits beyond glucose lowering with GLP-1 receptor agonists
Efficacy of repetitive transcranial magnetic stimulation (rTMS) adjunctive therapy for major depressive disorder (MDD) after two antidepressant treatment failures: Meta-analysis of randomized sham-controlled trials
It signals to your brain that you're full, even after eating less, reducing cravings and making healthy eating easier
TSH is the anchor, checked roughly every six to eight weeks during initiation and then every six to twelve months once stable, with free T4 drawn at each TSH check